Full text is available at the source.
Abstract
A substantial percentage of individuals experience the Dawn Phenomenon (DP), characterized by early-morning hyperglycemia without prior hypoglycemia.
- Patients with DP exhibit increased average blood glucose variability over a 24-hour period compared to those without DP.
- The condition poses significant challenges for managing diabetes through medication and diet.
- DP is associated with physiological increases in hormones like cortisol, catecholamines, and growth hormone during early morning hours.
- These hormones may elevate liver glucose production while reducing the body's sensitivity to insulin.
- Current therapeutic approaches mainly focus on alleviating symptoms rather than addressing the underlying causes of DP.
Simplified